← All trials
NCT02754141
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 20, 2016
- Primary completion
- Mar 11, 2019
- Completion date
- May 21, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 216
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Bristol-Myers SquibbLead sponsor
- Bristol-Myers SquibbStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.